USP22 and acute myeloid leukemia: Melo-Cardenas J. and co-authors reported that deubiquitylase ubiquitin-specific peptidase 22 (USP22) tissue-specific knockdown in HSCs of KrasG12D/+ mice resulted in the rapid occurrence of AML symptoms.